DOI: http://dx.doi.org/10.18203/2349-3933.ijam20162529

Atherogenic lipid profile of intrauterine growth retarded newborns

Avinash Namdeo Jadhao, Amit Ramesh Barapatre, Manoj Chandrakant Lokhande, Trupti Ramteke

Abstract


Background: Newborns with intrauterine growth restriction are under greater risk of coronary artery disease in future.  The objective was to compare the concentration of serum lipids of umbilical cord blood of neonates of intrauterine growth retardation with normal term neonates.

Methods: 50 newborns with intrauterine growth retardation and 50 normal term newborns, with 38 to 41 gestational weeks, were studied. Total cholesterol, triglycerides, HDL, LDL and VLDL cholesterol were measured in umbilical cord blood samples. The period of study was from January 2011 to October 2015. Study design: Hospital based prospective study.  Blood samples were collected from the study population in the neonatal unit and all serum lipid profile level was measured with all accuracy in a computerized automated biochemical analyzer in Biochemistry department. Statistical analysis were done by using student’s unpaired ‘t’ test by using graph pad prism software.

Results: TC concentration was significantly decreased in the IUGR compared AGA groups. LDL-C concentrations were decreased in the IUGR compared to the AGA group. TG concentration was significantly increased in IUGR as compared to the AGA group.

Conclusions: Intrauterine growth retarded newborns were with worse lipid profile in Indian IUGR neonates. Further research is needed into the determinants of fetal growth and to the ways preventing fetal under-nutrition.


Keywords


Lipid profile, Cord blood, Intrauterine growth retarded newborns, Atherogenesis

Full Text:

PDF

References


Underwood, James C. General ans SystematicPathology. London: Churchhill livingstone. 2009: pp.279.

Hales CN, Barker DJ, Clark PM, Fall C, C Osmond C, Winter PD, et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ. 1991; 303(6809):1019-22.

Barker DJP. Fetal origins of coronary heart disease. British Medical Journal. 1995;311:171-4.

Barker DJP. Mothers, babies and health in later life. Churchill Livingstone, Edinburgh; 1998.

Barker DJP, Clark MP. Fetal nutrition and disease in later life. Reviews of Reproduction.1997;2:105-12.

Harding JE. The nutritional basis of the foetal origins of adult disease. Int J Epidemiol. 2001;30:15-23.

Widdowson EM, McCance RA. A review: new thoughts on growth. Pediatr Res. 1975;9:154-6.

Desai M, Crowther NJ, Lucas A, Hales CN. Organ-selective growth in the offspring of protein-restricted mothers. Br J Nutr. 1996;76:591-603.

Woodall SM, Johnston BM, Breier BH, Gluckman PD. Chronic maternal under-nutrition in the rat leads to delayed postnatal growth and elevated blood pressure of offspring. Pediatr Res. 1996;40:438-43.

Neel JV. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet.1962;14:353-62.

Gluckman PD, Hanson MA. Developmental origins of disease paradigm: a mechanistic and evolutionary perspective. Pediatr Res. 2004;56(3):311-7.

Gluckman PD, Hanson MA. The biology of predictive adaptive responses, in The fetal matrix: evolution, development, and disease / Peter Gluckman, Mark Hanson. 2005,Cambridge University Press: New York. p.118-143.

Gluckman, PD, Hanson MA. The conceptual basis for the developmental origins of health and disease,in Developmental origins of health and disease, P.D. Gluckman and M.A. Hanson, Editors.2006,Cambridge University Press: Cambridge;New York. p.33- 50

Hale CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992;35(7):595-601

Gluckman PD, Hanson MA. Shaping our destiny: genes, environment, and their interactions, in The fetal matrix: evolution, development, and disease / Peter Gluckman, Mark Hanson. 2005, Cambridge University Press: New York. p.1-24.

Gluckman PD, Hanson MA, Beedle AS. Early life events and their consequences for later disease: a life history and evolutionary perspective. Am J Hum Biol. 2007;19(1):1-19.

Singh M. Preventive neonatology. Care of newborn. 2010;3:34-5

Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New Ballard Score expanded to include extremely premature infants. J Pediatr. 1991;119:417-23.

Pecks U, Brieger M, Schiessl B, Bauerschlag DO, Piroth D, Bruno B, Fitzner C, et al. Maternal and fetal cord blood lipids in intrauterine growth restriction. J Perinat Med. 2012;40(3):287-96.

Pecks U, Hirshman S, Mohaupt M, Schlembach D, Maass N, Rath W, et al. PP031. The fetal cholesterol acceptor potential in cord sera of intrauterine growth restricted (IUGR) neonates. Pregnancy Hypertension. 2013;3(2):78.

Pecks U, Caspers R, Schiessl B, Bauerschlag D, Piroth D, Maass N, Rath W et al. The evaluation of the oxidative state of low-density lipoproteins in intrauterine growth restriction and preeclampsia. Hypertens Pregnancy. 2012;31(1):156-65.

Koklu E, Kurtoglu S, Akcakus M, Koklu S, Buyukkayhan D, Gumus H, et al. Increased Aortic Intima-Media Thickness Is Related to Lipid Profile in Newborns with Intrauterine Growth Restriction. Horm Res. 2006;65(6):269-75.

Pecks UM, Wölter M, Röwer C, Koy C, Reimer T3, Rath W, et al. OS079. Fetal deglycosylated apolipoprotein C-III (Apo C-III0) concentration is altered in intrauterine growth restriction. Pregnancy Hypertens. 2012;2(3):220-1.

Napoli C, D’Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997;100:2680e90.

Colvin KT, Burke PL, Myatt L, Graf GA, Schroeder F, Woollett LA. Transport of maternal cholesterol to the fetus is affected by maternal plasma cholesterol concentrations in the golden Syrian hamster. J Lipid Res. 2009;50:1146e55.

Stefulj J, Panzenboeck U, Becker T, Hirschmugl B, Schweinzer C, Lang I, et al. Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1. Circ Res. 2009;104:600e8

Pavan L, Tsatsaris V, Hermouet A, Therond P, Evain-Brion D, Fournier T. Oxidized low-density lipoproteins inhibit trophoblastic cell invasion. J Clin Endocrinol Metab. 2004;89:1969e72.

Pavan L, Hermouet A, Tsatsaris V, Therond P, Sawamura T, Evain-Brion D, et al. Lipids from oxidized low-density lipoprotein modulate human trophoblast invasion: involvement of nuclear liver X receptors. Endocrinology. 2004;145:4583e91.

Aye IL, Waddell BJ, Mark PJ, Keelan JA. Placental ABCA1 and ABCG1 transporters efflux cholesterol and protect trophoblasts from oxysterol induced toxicity. Biochim Biophys Acta. 2010;1801:1013e24.

Zhu Y, Liao H, Xie X, Yuan Y, Lee TS, Wang N, et al. Oxidized LDL downregulates ATP-binding cassette transporter-1 in human vascular endothelial cells via inhibiting liver X receptor (LXR). Cardiovasc Res 2005;68:425e32.

Hossain MA, Islam MN, Shahidullah M, Akhter H. Serum triglyceride level in IUGR babies and its comparison with preterm AGA and term normal babies. Mymensingh Med J. 2006;15(2):180-2.

Molina M, Casanueva V, Cid X, Ferrada MC, Ferrada MC, Pérez R, Dios G, et al. Lipid profile in newborns with intrauterine growth retardation. Rev Med Chil. 2000;128(7):741-8.

Pecks U, Caspers R, Sosnowsky K, Rath W, Huppertz B. PP014. Estimating fully and minimal oxidized low density lipoprotein accumulation in placental tissue in intrauterine growth restriction and healthy controls. Pregnancy Hypertens. 2012;2(3):248.